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Abstract 
Amelanotic melanoma is met only in 2-
8% of cases with malignant melanoma. The 
incidence of brain metastases in patients 
with malignant melanoma ranges from 6-
43% of cases. Brain metastases are 
frequently associated with malignant 
melanoma after the intratumorale 
hemorrhage. We choose to present the case 
of 58-years-old men with a frontal brain 
metastasis of amelanotic malignant 
melanoma. 
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Introduction 
Cutaneous melanoma is one of the most 
common tumors that metastasized in the 
brain after lung cancer, breast cancer and 
unspecified origin. Most common location 
of malignant melanoma is the skin, retina, 
brain and nail bed. In about 14% of cases 
the location of the primary tumor remains 
unknown. The incidence of brain 
metastases in patients with malignant 
melanoma ranges from 6-43% of cases. In 
this article we present a patient with 
metastatic amelanotic malignant melanoma. 
Case presentation 
A 58-years-old man, operated about two 
years ago for a right latero-cervical tumor 
(histopathology: amelanotic malignant 
melanoma) was admitted in the 
Neurosurgery Clinic Emergency Hospital 
"Bagdasar-Arseni" Bucharest, for seizures 
and intracranial hypertension syndrome.  
Personal history of pathologic: 
amelanotic malignant melanoma, duodenal 
ulcer. 
Cranial MRI (native and contrast) 
highlights a left fronto-basal tumor, with 
high signal intensity on T1 weighted images 
(T1WI) and high signal intensity on T2 
weighted images (T2WI), policystic, about 
54/46/50 mm in size, with perilesional 
edema and mass effect that moves the 
midline to the right (Figure 1A, 1B, 1C). 
MRAngiography (MRA) reveals a shift to 
the right ACA (Figure 1D). 
Thoracic and abdominal CT showed no 
evidence of space replacement processes 
(Figure 2). 
The patient underwent surgery: a left 
fronto-basal bone flap was performed 
showing a yellow-gray tumor, bleeding, 
with multiple areas of intratumoral 
necrosis. Tumor ablation under optical 
magnification was completely at once, with 
a safety zone of about 1 cm peritumoral.  
Histological examination (Figure 3) 
diagnosed the tumor probably germ cells or 
metastasis of malignant amelanotic 
melanoma, therefore recommend 
immunohistochemical examination. The 
result of immunohistochemical examination 
was amelanoticmalignant melanoma. 
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Figure 1 Preoperative MRI: A Axial section;  
B Sagittal section; C Coronal section;  
D MR Angiography 
 
Postoperatively the patient is aware, 
cooperative, and without superadded motor 
deficits. Drain was suppress about 24 hours 
after surgery and the patient starts 
recovering. Postoperative CT scan show no 
tumor remains, preserved median line and 
left frontobasal flap bone (Figure 4). 
During hospitalization the patient has 
melena, so abdominal ultrasound and upper 
gastrointestinal endoscopy was performed. 
No pathological process was found. 
Surgically cured patient is discharged 
with the recommendation of expert advice 
in clinical oncology and neurosurgical 
control over 2 months. 
Discussion 
Amelanotic melanoma is met only in 2-
8% of cases with malignant melanoma. It is 
a skin lesion which appears as small 
abnormal pigmented, reddish or pink 
lesions, of irregular shape. Many times 
these lesions can be confused with other 
tumors (basal cell carcinoma) or 
inflammatory processes.  
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Risk factors for the occurrence of brain 
metastases include: 
- Location in the head or neck 
- High Breslow index (IB>1 mm) (4) 
- Index Clark IV and V(2) 
- Protruding or ulcerated skin 
lesions(7) 
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Figure 2 A Thoracic CT scan without intravenous 
contrast; B Thoracic CT scan with intravenous 
contrast; C Abdominal CT scan 
 
 
 
 
Figure 3 Conventional histological examination 
 
 
 
 
544          V. Prună et al          Brain metastasis of amelanotic malignant melanoma 
 
 
 
 
 
 
Figure 4 Postoperative CT scan 
 
Brain metastases are frequently 
associated with malignant melanoma after 
the intratumorale hemorrhage, and clinical 
appearance may mimic a stroke or even a 
subdural hematoma. 
The current treatment includes: 
- Surgery 
- Radiosurgery (Gamma-Knife or 
LINAC) 
- Radiotherapy WBRT 
- Chemotherapy 
- Immunotherapy 
- Multimodal 
The goal of treatment is to stabilize 
disease and improve quality of life(6). 
Surgery is the treatment of choice for 
tumors with a volume of more than 3 cm3. 
Tumor resection is preferred to be in 
block(5), and complete resection with a 
safety peritumoral margin about 0.5 
cm(10). It was found that block tumor 
resection improved survival and local 
recurrence also decreases. If the tumor 
resection was radical, all clinical trials have 
shown that adjuvant therapy may be 
optional. This rule is applied only in 
completely resected tumors, otherwise 
“Whole-Brain” radiation therapy must 
continue or stereotactic radiosurgery 
(Gamma-Knife or LINAC). 
Stereotactic radiosurgery (Gamma-Knife 
or LINAC) is a therapeutic alternative(3, 8, 
11). 
The advantages of radiosurgery are(9): 
- Low morbidity 
- Low toxicity 
- Reduces the duration of 
hospitalization 
The role of whole-brain radiation 
therapy remains controversial because of 
low sensitivity and high risk of developing 
dementia in younger patients(1). The 
prognosis of patients with brain metastases 
after malignant melanoma is usually infaust. 
Conclusions 
Amelanotic melanoma is a rare 
malignant skin lesion which often provides 
diagnostic problems. Surgery and radiation 
Gamma-Knife Stereotactic type or LINAC 
remain the main methods of treatment for 
brain metastasis from amelanotic malignant 
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melanoma. An early and correct diagnosis 
of skin lesion followed by appropriate 
treatment reduces the risk of developing 
brain metastasis and increases quality of life. 
Patients with metastases after this type of 
injury usually have a poor prognosis. 
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